For the last few months, our team at Endpoints News has been looking over dozens of new startups to find the ones we think are pursuing the most interesting scientific ideas, backed with the right financing and the smart leadership that can create the breakthroughs of tomorrow.
The result of that work is our annual Endpoints 11 list, which we’ll unveil in Boston on Thursday, Sept. 26. The gala event isn’t just a chance to meet and mingle with some of the most exciting private companies in the industry. We’ll also be sitting down for a conversation with legendary MIT researcher and Moderna co-founder Bob Langer for a one-on-one conversation.
Getting picked as one of this year’s 11 companies isn’t a guarantee of success. We look for big bets that will change the lives of patients if they succeed but might create some major fallout if they fail.
And we’ve got a good track record. Of the 55 companies we’ve put on our list since 2018, more than a third have IPO’d, been acquired or brought drugs to market.
I hope you’ll join us in Boston on Sept. 26. Get your ticket (save 10% by using the code 10EDIT), and say hello to me and the other members of our newsroom. It’s going to be a great evening!
— Drew Armstrong, Executive Editor